Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder affecting 10 — 20 per cent of people. Abdominal pain, bloating and altered bowel habit significantly affect patient’s quality of life and can force them to take days off work.

Previous research (the ACTIB trial) led by Professor Hazel Everitt at the University of Southampton in collaboration with researchers at King’s College London, showed that that Cognitive Behavioural Therapy (CBT) tailored specifically for IBS and delivered over the telephone or through an interactive website is more effective in relieving the symptoms of IBS than current standard care one year after treatment.

This 24 month follow up research published in Lancet Gastroenterology and Hepatology this week has shown that benefits continue two years after treatment despite patients having no further therapy after the initial CBT course. These results are important as previously there was uncertainty whether the initial benefits could be sustained in the long term. Currently there is limited availability of CBT for IBS in a resource constrained NHS but this research indicates that easily accessible treatment could be provided to a large number of patients and provide them with effective, long-term relief.

Professor Everitt added: “the fact that both telephone and web based CBT sessions were shown to be effective treatments is a really important and exciting discovery. Patients are able to undertake these treatments at a time convenient to them, without having to travel to clinics and we now know that the benefits can last long term.”



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What do bees make?

Explore More

Plant virus plus immune cell-activating antibody clear colon cancer in mice, prevent recurrence

A new combination therapy to combat cancer could one day consist of a plant virus and an antibody that activates the immune system’s “natural killer” cells, shows a study by

Global trial confirms benefit of antacids on bleeding prevention for ventilated patients

A widely available drug helps prevent upper gastrointestinal bleeding in critically ill adults on a breathing machine, according to the results of a global study and meta-analysis led by researchers

Multidisciplinary approach more effective for gut disorders

Patients with gastrointestinal disorders — such as irritable bowel syndrome (IBS) and constipation — have greater symptom relief and improved wellbeing when treated at multidisciplinary clinics, new research shows. Researchers